Todd Harris
Founder bij TYRA BIOSCIENCES, INC.
Vermogen: 25 M $ op 31-03-2024
Profiel
Todd J.
Harris is the founder of Tyra Biosciences, Inc. (founded in 2018) and Sienna Biopharmaceuticals, Inc. (founded in 2010).
He is currently the President, CEO, Treasurer & Director at Tyra Biosciences, Inc. and the Director & Head-Corporate Development at Sienna Biopharmaceuticals, Inc. Additionally, Dr. Harris is currently working as a Director at Primmune Therapeutics, Inc. since 2019.
Dr. Harris has a doctorate degree from the Massachusetts Institute of Technology, an undergraduate degree from Brigham Young University, and a graduate degree from the University of California San Diego.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC
2.86% | 15-03-2024 | 1 504 577 ( 2.86% ) | 25 M $ | 31-03-2024 |
Actieve functies van Todd Harris
| Bedrijven | Functie | Begin |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Founder | 02-08-2018 |
Primmune Therapeutics, Inc.
 Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Director/Board Member | 01-10-2019 |
Eerdere bekende functies van Todd Harris
| Bedrijven | Functie | Einde |
|---|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Founder | 01-07-2018 |
Opleiding van Todd Harris
| Massachusetts Institute of Technology | Doctorate Degree |
| Brigham Young University | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Commercial Services |
